Cargando…

Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: An Indian perspective

BACKGROUND: A number of diabetic patients with diabetic neuropathy, in India, were treated with epalrestat, an aldose reductase inhibitor. In this study, more than 2000 patients with diabetic neuropathy, who were treated with epalrestat for 3-12 months, were analyzed to assess the efficacy and the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, S. R., Sharma, Nalini
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771994/
https://www.ncbi.nlm.nih.gov/pubmed/19893679
http://dx.doi.org/10.4103/0972-2327.44558

Ejemplares similares